FDA clears RevealDX’s AI lung nodule diagnostic
RevealAI-Lung is now reimbursable in the US under the Medicare Outpatient Prospective Payment System (OPPS) at a rate of $650....
RevealAI-Lung is now reimbursable in the US under the Medicare Outpatient Prospective Payment System (OPPS) at a rate of $650....
bioAffinity Technologies, Inc. (NASDAQ: BIAF) has emerged as a standout performer in the financial markets today, September 26, 2025, with...
bioAffinity Technologies, Inc. (NASDAQ: BIAF) has emerged as a standout performer in the financial markets today, September 26, 2025, with...
What is the Skin Cancer Diagnostic Market Size? The global skin cancer diagnostic market size accounted for USD 8.54 billion...
In the rapidly evolving landscape of medical imaging, Hyperfine, Inc. (Nasdaq: HYPR) has emerged as a trailblazer with its AI-powered,...
Market Size & Trends The global diagnostic dermatology imaging devices market size was estimated at USD 4.93 billion in 2024...
Speaking at Hospital Healthcare Europe’s Clinical Excellence in Respiratory Care event, our panel of three respiratory experts considered the use...
Experts at Hackensack Meridian Jersey Shore University Medical Center in Neptune are now providing patients with minimally invasive, robotic-assisted bronchoscopy...